These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8722520)

  • 1. Public goods and fair prices. Balancing technological innovation with social well-being.
    Brody B
    Hastings Cent Rep; 1996; 26(2):5-11. PubMed ID: 8722520
    [No Abstract]   [Full Text] [Related]  

  • 2. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients.
    Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
    Bulleit TN
    J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
    [No Abstract]   [Full Text] [Related]  

  • 4. AIDS and drug pricing: in search of a policy.
    Salbu SR
    Wash Univ Law Q; 1993; 71(3):691-734. PubMed ID: 11652750
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug prices: real problem, wrong solution.
    Kennedy D
    Science; 2001 Jun; 292(5523):1797. PubMed ID: 11397914
    [No Abstract]   [Full Text] [Related]  

  • 6. The incorporation of new technologies into genetic services; the importance of government support.
    Holtzman NA
    Birth Defects Orig Artic Ser; 1992; 28(3):126-30. PubMed ID: 1489950
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare's End-Stage Renal Disease Program: its development and implications for health care policy.
    Southern HB
    Harvard J Legis; 1989; 26(1):225-62. PubMed ID: 11659153
    [No Abstract]   [Full Text] [Related]  

  • 8. High-tech cardiology--issues and costs: a panel discussion.
    Atkins GL; Beller GA; Paine LS; Thorup OA
    Pharos Alpha Omega Alpha Honor Med Soc; 1985; 48(3):31-7. PubMed ID: 3929280
    [No Abstract]   [Full Text] [Related]  

  • 9. Innovation in biomedicine: can stem cell research lead the way to affordability?
    Goozner M
    PLoS Med; 2006 Feb; 3(5):e126. PubMed ID: 16492088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerating technology transfer: new relationships for academia, industry and government.
    Satava RM
    Stud Health Technol Inform; 1998; 50():1-6. PubMed ID: 10180523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statutory and ethical barriers in the patenting of medical and surgical procedures.
    Lafferty WB
    John Marshall Law Rev; 1996; 29(4):891-921. PubMed ID: 11657451
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical technology and competitiveness in the world market: reinventing the environment for innovation.
    George WW
    Food Drug Law J; 1995; 50(4):477-84. PubMed ID: 10343014
    [No Abstract]   [Full Text] [Related]  

  • 13. NIH 'should help sharing of research tools'.
    Wadman M
    Nature; 1998 Jun; 393(6685):505. PubMed ID: 9634219
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene patents--a pharmaceutical perspective.
    Tribble JL
    Camb Q Healthc Ethics; 1998; 7(4):429-32. PubMed ID: 9752585
    [No Abstract]   [Full Text] [Related]  

  • 15. If only it were so: medical physics, U.S. human radiation experiments, and the Final Report of the President's Advisory Committee (ACHRE).
    Martensen R
    Med Humanit Rev; 1997; 11(2):21-36. PubMed ID: 11645853
    [No Abstract]   [Full Text] [Related]  

  • 16. The worst of times for technological innovation.
    Del Guercio LR
    Bull Am Coll Surg; 1980 Jun; 65(6):13-4. PubMed ID: 10246600
    [No Abstract]   [Full Text] [Related]  

  • 17. Widespread adoption of health information technology could save $162 billion a year, but the federal government needs to help.
    Comput Inform Nurs; 2005; 23(6):295-6. PubMed ID: 16292041
    [No Abstract]   [Full Text] [Related]  

  • 18. Taking the profit out of biomedical research tools.
    Flores MA
    Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of medical-technology strategies: effects of coverage and reimbursement (first of two parts).
    Bunker JP; Fowles J; Schaffarzick R
    N Engl J Med; 1982 Mar; 306(10):620-4. PubMed ID: 7035944
    [No Abstract]   [Full Text] [Related]  

  • 20. Technology assessment. Motivation, capability, and future directions.
    Fineberg HV
    Med Care; 1985 May; 23(5):663-71. PubMed ID: 4010354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.